Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Janssen
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
An Efficacy Study for Epoetin alfa in Anemic Patients with Myelodysplastic Syndromes
To demonstrate that epoetin alfa treatment is better at improving anemia outcome (as evaluated by Erythroid response – International Working Group [IWG] 2006) in subjects with International Prognostic...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Janssen
Update Il y a 4 ans
Étude COLUMBA : étude de phase 3 randomisée comparant l’efficacité du daratumumab administré par voie intraveineuse à celle du daratumumab co-formulé avec la hyaluronidase humaine recombinante PH20 par voie sous cutanée chez des patients ayant un myélome multiple. [essai clos aux inclusions]
Le myélome multiple est une maladie de la moelle osseuse caractérisée par la multiplication dans la moelle osseuse d’un plasmocyte anormal. Le rôle des plasmocytes est de produire les anticorps (immun...
Country
France
organs
Myélomes
Specialty
Immunothérapie - Vaccinothérapie
Essai clos aux inclusions
More information
Woman Max 99 years
Patricia Janssen, BSN, MPH, PhD
Update Il y a 4 ans
Impact of Doula Support on Childbirth Outcomes for Women Undergoing a Vaginal Birth After Cesarean (VBAC)
The purpose of this study is to evaluate the impact of doula support on childbirth outcomes of women who are eligible for and attempting to have a Vaginal Birth After Cesarean (VBAC). Doul...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Janssen, MD / DO
Update Il y a 4 ans
An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation
The aim of this trial is to evaluate if P-15 bone putty (investigational device) is not inferior in effectiveness and safety to local autologous bone (control device) when applied in instr...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Harry LA Janssen, MD, PhD
Update Il y a 4 ans
KRN7000 in Chronic Hepatitis B
The purpose of this trial is to determine the safety, tolerability and effectiveness of KRN7000 for chronic hepatitis B infection.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 4 ans
A Randomized, Double-Blind, Parallel Group Non-inferiority Study of Flexibly Dosed Paliperidone Palmitate(25, 50, 75, 100 mg eq) Administered Every 4 weeks and Flexibly Dosed Risperdal Consta (25, 37.5, 50 mg) Administered Every 2 weeks in Subjects with Schizophrenia
The primary objective of this study is to demonstrate that paliperidone palmitate and RISPERDALCONSTA have comparable efficacy. The safety and tolerability of paliperidone palmitate inmaintenance ther...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Janssen
Update Il y a 6 ans
Étude 42756493BLC2001 : étude de phase 2, évaluant l’efficacité et la tolérance de deux schémas administration du JNJ-42756493, un inhibiteur de FGFR, chez des patients ayant un cancer urothélial métastatique ou non-résécable chirurgicalement et présentant des altérations génomiques du FGFR.
Etude de phase II, multicentrique, en ouvert, avec 2 bras de traitement, visant à évaluer l'efficacité et la sécurité d’emploi de deux schémas posologiques d’un pan-inhibiteur de la tyrosine kinase de...
Country
France
organs
Appareil urinaire - autres
Specialty
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman and Man
Between 18 years
and 99 years
Janssen-Cilag International N.V
Update Il y a 4 ans
LYM3002 : Essai de phase 3, randomisé, évaluant l’efficacité de deux schémas thérapeutiques, VcR-CAP ou R-CHOP comprenant rituximab, cyclophosphamide, doxorubicine, prednisone associés au bortézomib ou à la vincristine respectivement, chez des patients ayant un lymphome à cellules du manteau. [essai clos aux inclusions]
L’objectif de cet essai est de déterminer l’association thérapeutique la plus efficace parmi deux schémas, VcR-CAP ou R-CHOP, chez des patients ayant un lymphome à cellules du manteau nouvellement dia...
Country
France
organs
Lymphomes non hodgkinien
Specialty
Chimiothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 4 ans
A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Subjects With Premature Ejaculation
To demonstrate that dapoxetine (30 or 60 mg prn) can prolong intravaginal ejaculatory latency time (IELT) as measured by stopwatch when compared to placebo in men with PE during the 24-week treatment ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
Update Il y a 4 ans
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of JNJ-16269110 on Hepatic Triglyceride Content in Obese Subjects
To investigate mean changes in Hepatic Triglyceride Content (HTGC) from baseline to week 6 and 12 by 1H-Magnetic Resonance Spectroscopy (MRS) in obese subjects treated with JNJ-16269110: 10 mg bid, 1...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next